Bay Harbor Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Bay Harbor Wealth Management's BMY Position: Q2 2026 in Review
Bay Harbor Wealth Management increased its Bristol-Myers Squibb (BMY) stake by 420% in Q2 2026, buying an estimated $60.5K and bringing the position to 1,304 shares worth $75.1K. The position accounts for 0.02% of the portfolio, ranked #127.
Bay Harbor Wealth Management first reported a position in BMY in Q4 2018 and has held it in 24 quarters since. The position peaked at $266K in Q3 2019. 2,524 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Bay Harbor Wealth Management held 1,304 shares of Bristol-Myers Squibb worth $75.1K as of Q2 2026.
- Bay Harbor Wealth Management bought 1,053 Bristol-Myers Squibb shares in Q2 2026, an estimated $60.5K.
- Bristol-Myers Squibb made up 0.02% of Bay Harbor Wealth Management's portfolio in Q2 2026, its #127 holding.
- Bay Harbor Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2018 and has held it in 24 quarters since.
- Bay Harbor Wealth Management's Bristol-Myers Squibb position peaked at $266K in Q3 2019.
- 2,524 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Bay Harbor Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.